Correlation Between Dyadic International and Predictive Oncology

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Dyadic International and Predictive Oncology at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Dyadic International and Predictive Oncology into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Dyadic International and Predictive Oncology, you can compare the effects of market volatilities on Dyadic International and Predictive Oncology and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Dyadic International with a short position of Predictive Oncology. Check out your portfolio center. Please also check ongoing floating volatility patterns of Dyadic International and Predictive Oncology.

Diversification Opportunities for Dyadic International and Predictive Oncology

0.45
  Correlation Coefficient

Very weak diversification

The 3 months correlation between Dyadic and Predictive is 0.45. Overlapping area represents the amount of risk that can be diversified away by holding Dyadic International and Predictive Oncology in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Predictive Oncology and Dyadic International is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Dyadic International are associated (or correlated) with Predictive Oncology. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Predictive Oncology has no effect on the direction of Dyadic International i.e., Dyadic International and Predictive Oncology go up and down completely randomly.

Pair Corralation between Dyadic International and Predictive Oncology

Given the investment horizon of 90 days Dyadic International is expected to under-perform the Predictive Oncology. But the stock apears to be less risky and, when comparing its historical volatility, Dyadic International is 1.36 times less risky than Predictive Oncology. The stock trades about -0.09 of its potential returns per unit of risk. The Predictive Oncology is currently generating about -0.06 of returns per unit of risk over similar time horizon. If you would invest  96.00  in Predictive Oncology on April 23, 2025 and sell it today you would lose (17.00) from holding Predictive Oncology or give up 17.71% of portfolio value over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthWeak
Accuracy100.0%
ValuesDaily Returns

Dyadic International  vs.  Predictive Oncology

 Performance 
       Timeline  
Dyadic International 

Risk-Adjusted Performance

Very Weak

 
Weak
 
Strong
Over the last 90 days Dyadic International has generated negative risk-adjusted returns adding no value to investors with long positions. Despite weak performance in the last few months, the Stock's basic indicators remain fairly strong which may send shares a bit higher in August 2025. The recent confusion may also be a sign of long-lasting up-swing for the firm traders.
Predictive Oncology 

Risk-Adjusted Performance

Very Weak

 
Weak
 
Strong
Over the last 90 days Predictive Oncology has generated negative risk-adjusted returns adding no value to investors with long positions. Despite weak performance in the last few months, the Stock's basic indicators remain fairly strong which may send shares a bit higher in August 2025. The recent confusion may also be a sign of long-lasting up-swing for the firm traders.

Dyadic International and Predictive Oncology Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Dyadic International and Predictive Oncology

The main advantage of trading using opposite Dyadic International and Predictive Oncology positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Dyadic International position performs unexpectedly, Predictive Oncology can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Predictive Oncology will offset losses from the drop in Predictive Oncology's long position.
The idea behind Dyadic International and Predictive Oncology pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Commodity Channel module to use Commodity Channel Index to analyze current equity momentum.

Other Complementary Tools

Portfolio Diagnostics
Use generated alerts and portfolio events aggregator to diagnose current holdings
Stock Screener
Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook.
Correlation Analysis
Reduce portfolio risk simply by holding instruments which are not perfectly correlated
Instant Ratings
Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance
Efficient Frontier
Plot and analyze your portfolio and positions against risk-return landscape of the market.